Diploma (LON:DPLM) had its target price hoisted by equities researchers at Barclays from GBX 1,190 ($15.55) to GBX 1,225 ($16.01) in a note issued to investors on Tuesday. The firm currently has an “equal weight” rating on the stock. Barclays’ target price suggests a potential downside of 6.20% from the company’s previous close.

Other equities research analysts also recently issued research reports about the stock. Peel Hunt reissued an “add” rating and set a GBX 1,400 ($18.29) price target on shares of Diploma in a research report on Monday. Jefferies Financial Group raised their price target on shares of Diploma from GBX 1,320 ($17.25) to GBX 1,560 ($20.38) and gave the company a “buy” rating in a research report on Wednesday, August 29th. Berenberg Bank reissued a “buy” rating and set a GBX 1,365 ($17.84) price target on shares of Diploma in a research report on Thursday, September 6th. Numis Securities raised their price target on shares of Diploma from GBX 1,275 ($16.66) to GBX 1,355 ($17.71) and gave the company a “hold” rating in a research report on Wednesday, August 29th. Finally, Royal Bank of Canada reissued a “sector performer” rating and set a GBX 1,280 ($16.73) price target on shares of Diploma in a research report on Monday. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of GBX 1,364.17 ($17.83).

Shares of LON DPLM opened at GBX 1,306 ($17.07) on Tuesday. Diploma has a fifty-two week low of GBX 1,010 ($13.20) and a fifty-two week high of GBX 1,270 ($16.59).

Diploma (LON:DPLM) last announced its earnings results on Monday, November 19th. The company reported GBX 56.40 ($0.74) earnings per share for the quarter, beating the Zacks’ consensus estimate of GBX 55.20 ($0.72) by GBX 1.20 ($0.02).

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in North America, Europe, and internationally. It operates through Life Sciences, Seals, and Controls business sectors. The Life Sciences sector supplies consumables and instruments for the diagnostic testing of blood, tissue, and other samples in hospital pathology laboratories; electrosurgery equipment and consumables for use in hospital operating rooms; and surgical medical devices, and related consumables and services to GI endoscopy suites in hospitals and private clinics.

Featured Story: How Investors Use a Balance Sheet

Analyst Recommendations for Diploma (LON:DPLM)

Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.